Oxford Biomedica plc (OXBDF)
OTCMKTS · Delayed Price · Currency is USD
7.35
+0.62 (9.21%)
At close: Aug 21, 2025
Oxford Biomedica Market Cap
Oxford Biomedica has a market cap or net worth of $961.09 million as of September 5, 2025. Its market cap has increased by 97.20% in one year.
Market Cap
961.09M
Enterprise Value
1.03B
Revenue
161.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
$7.35
Market Cap Chart
Since September 22, 1997, Oxford Biomedica's market cap has increased from 27.87M to 961.09M, an increase of 3,348.06%. That is a compound annual growth rate of 13.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 961.09M | 72.54% |
| Dec 31, 2024 | 557.04M | 105.34% |
| Dec 29, 2023 | 271.27M | -47.15% |
| Dec 30, 2022 | 513.24M | -64.22% |
| Dec 31, 2021 | 1.43B | 23.95% |
| Dec 31, 2020 | 1.16B | 76.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.00M |
| HealthLynked | 499.79M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |